this post was submitted on 23 Jan 2026
3 points (100.0% liked)

Green & indigenous News

129 readers
81 users here now

A community for Green & indigenous news!

founded 1 month ago
MODERATORS
 

A vaccine developed to tackle Streptococcus suis, an economically damaging disease endemic in the global pig population, has outperformed a leading commercially available vaccine in a challenge trial. The trial showed the vaccine candidate—developed by an international consortium including The Vaccine Group (TVG), the University of Plymouth and Moredun Scientific Limited—to be effective against a heterologous serotype of the disease.


From Biology News - Evolution, Cell theory, Gene theory, Microbiology, Biotechnology via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here